Evidence map›Paper›PMID 30740857›Full record

ArticleJournal of thrombosis and haemostasis : JTH2019

The endothelial lectin clearance receptor CLEC4M binds and internalizes factor VIII in a VWF-dependent and independent manner.

Laura L Swystun, Colleen Notley, Ilinca Georgescu, Jesse D Lai, Kate Nesbitt, Paula D James, David Lillicrap

Open access · bronzeAbstract read
In one paragraph

Article in Journal of thrombosis and haemostasis : JTH, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 45 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. The Scavenger Function of LSECs, a Regulator of Liver Diseases.Current issues in molecular biology · 2026
    Review
  4. Review
  5. Review
  6. Article
  7. Large deletions in theResearch and practice in thrombosis and haemostasis · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Anticoagulant therapy in COVID-19: A narrative review.Clinical and translational science · 2023
    Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. von Willebrand disease and von Willebrand factor.Haemophilia : the official journal of the World Federation of Hemophilia · 2022
    Article
  18. Article
  19. Combination ofJournal of clinical medicine · 2022
    Article
  20. Reduction ofFrontiers in cardiovascular medicine · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Laura L SwystunDepartment of Pathology and Molecular Medicine, Queen's University, Kingston, ON, Canada.
Colleen NotleyDepartment of Pathology and Molecular Medicine, Queen's University, Kingston, ON, Canada.
Ilinca GeorgescuDepartment of Pathology and Molecular Medicine, Queen's University, Kingston, ON, Canada.
Jesse D LaiDepartment of Pathology and Molecular Medicine, Queen's University, Kingston, ON, Canada.ORCID 0000-0003-2916-2954
Kate NesbittDepartment of Pathology and Molecular Medicine, Queen's University, Kingston, ON, Canada.
Paula D JamesDepartment of Medicine, Queen's University, Kingston, ON, Canada.
David LillicrapDepartment of Pathology and Molecular Medicine, Queen's University, Kingston, ON, Canada.
Queen's University · CA

Funding

Zimmerman Program for the Molecular and Clinical Biology of VWDP01HL081588 · NHLBI · VERSITI WISCONSIN, INC. · PI MONTGOMERY, ROBERT R · 2005 to 2016
$19.3M
Zimmerman Program on the Biology of VWDP01HL144457 · NHLBI · VERSITI WISCONSIN, INC. · PI MONTGOMERY, ROBERT R · 2019 to 2023
$13.3M
CIHR FDN 154285NHLBI NIH HHS P01 HL081588NHLBI NIH HHS P01 HL144457
6 · The paper itself

Abstract

Essentials CLEC4M is an endocytic receptor for factor FVIII. CLEC4M interacts with FVIII in a VWF-dependent and independent manner. CLEC4M binds to mannose-containing glycans on FVIII. CLEC4M internalization of FVIII involves clathrin coated pits. SUMMARY: Background von Willebrand factor (VWF) and factor VIII (FVIII) circulate in the plasma as a non-covalent complex, and the majority of FVIII is likely to be cleared by VWF-dependent pathways. Clearance of VWF-free FVIII is rapid and underlies the pathological basis of some quantitative FVIII deficiencies. The receptor pathways that regulate the clearance of VWF-bound and VWF-free FVIII are incompletely uncharacterized. The human liver-expressed endothelial lectin CLEC4M has been previously characterized as a clearance receptor for VWF, although its influence on FVIII is unknown. Objective The interaction between FVIII and CLEC4M was characterized in the presence or absence of VWF. Methods FVIII interactions with CLEC4M were evaluated by in vitro cell-based and solid phase binding assays. Interactions between FVIII and CLEC4M or liver sinusoidal endothelial cells were evaluated in vivo by immunohistochemistry. Results CLEC4M-expressing HEK 293 cells bound and internalized recombinant and plasma-derived FVIII through VWF-dependent and independent mechanisms. CLEC4M binding to recombinant FVIII was dependent on mannose-exposed N-linked glycans. CLEC4M mediated FVIII internalization via a clathrin-coated pit-dependent mechanism, resulting in transport of FVIII from early and late endosomes for catabolism by lysosomes. In vivo hepatic expression of CLEC4M after hydrodynamic liver transfer was associated with a decrease in plasma levels of endogenous murine FVIII:C in normal mice, whereas infused recombinant human FVIII was associated with sinusoidal endothelial cells in the presence or absence of VWF. Conclusions These findings suggest that CLEC4M is a novel clearance receptor that interacts with mannose-exposed glycans on FVIII in the presence or absence of VWF.

Indexed as

EndocytosisAnimalsBinding SitesCell Adhesion MoleculesClathrinEndosomesEndothelial CellsFactor VIIIHEK293 CellsHumansLectins, C-TypeLiverLysosomesMice, Inbred C57BLMice, KnockoutProtein BindingCell Adhesion MoleculesClathrinCLEC4M protein, humanF8 protein, humanFactor VIIILectins, C-TypeReceptors, Cell Surfacevon Willebrand Factorendocytosisendothelial cellFactor VIIIglycanlectin receptorvon Willebrand factor

Identifiers

PMID30740857
PMCPMC7083068
OpenAlexW2912715303

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.